Hypothesis

The state of intracellular protein aggregation—whether it represents a protective, chaperone‑enriched sequestration or a pathological, amyloid‑like deposit—determines the quantitative and qualitative features of circulating cell‑free DNA (cfDNA) released from stressed cells. Specifically, protective aggregation yields a cfDNA signature enriched in short fragments (<150 bp) and hypomethylated repetitive elements, whereas pathological aggregation drives release of longer fragments (>200 bp) with hypermethylation at inflammatory CpG sites.

Mechanistic Basis

1. Chaperone‑buffered aggregation limits necrotic death. When soluble misfolded proteins are safely deposited in HSP70/HSP90‑rich aggregates (as seen in long‑lived organisms) [3], cytosolic stress remains sub‑lethal, favoring apoptosis. Apoptotic nucleases generate mono‑ and oligo‑nucleosomal cfDNA (~150 bp) [1]. Concurrently, the apoptotic caspase cascade preferentially demethylates LINE‑1 and SINE repeats via TET‑mediated oxidation, producing the hypomethylated repeat‑rich cfDNA observed in younger individuals [1].

2. Amyloid‑like overload triggers secondary necrosis. When aggregation exceeds chaperone capacity, fibrillar assemblies accumulate, destabilizing lysosomes and membranes, pushing cells toward secondary necrosis [2]. Necrotic DNA shearing yields longer, randomly sized cfDNA fragments (>200 bp) [1]. Moreover, necrosis‑associated HMGB1 release activates NF‑κB, driving de novo methylation of CpG sites in promoters of IL6, TNF and other inflammaging loci, a shift captured by current cfDNA methylation clocks [1,5].

3. Feedback via nuclear lamina stiffness. Persistent proteolytic stress alters lamin A/C phosphorylation, increasing nuclear rigidity. Stiffer nuclei resist apoptotic DNA fragmentation, biasing cfDNA toward longer pieces, while softer nuclei (typical of chaperone‑buffered states) permit efficient internucleosomal cleavage.

Predictions and Experimental Design

• Prediction 1: In human plasma, samples with high levels of soluble HSP70‑co‑immunoprecipitated aggregates (detected by native PAGE) will show a higher proportion of cfDNA fragments <150 bp and reduced methylation at LINE‑1 CpGs compared with samples enriched in thioflavin‑S‑positive amyloid aggregates.
• Prediction 2: Pharmacologically enhancing chaperone activity (e.g., with geranylgeranyl‑acetate) in aged mice will shift cfDNA from long to short fragments and decrease inflammaging CpG methylation, without altering total cfDNA concentration.
• Prediction 3: Inducing lysosomal rupture (e.g., with Leu‑Leu‑OMe) in cultured fibroblasts will increase amyloid‑like aggregates, elevate necrotic cfDNA (>200 bp), and increase methylation at NF‑κB target sites.

Experimental readouts: cfDNA fragment size by Bioanalyzer, methylation by targeted bisulfite sequencing of the 48‑CpG clock plus LINE‑1/SINE assays, aggregate state by filter‑trap assay and conformational antibodies (OC for amyloid, A11 for oligomers).

Potential Implications

If validated, this framework would re‑interpret cfDNA methylation clocks not merely as passive age meters but as dynamic reporters of proteostatic strategy. It would enable discrimination between adaptive aggregation (a hallmark of healthy longevity) and maladaptive aggregation (a driver of frailty), guiding interventions that bolster chaperone networks rather than indiscriminately dissolving aggregates.

References

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC11318736/ [2] https://elifesciences.org/articles/43059 [3] https://www.fightaging.org/archives/2015/05/protein-aggregation-as-a-protective-mechanism/ [4] https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1000450 [5] https://pubmed.ncbi.nlm.nih.gov/11525876/